TSC2 and acute myeloid leukemia: For these patients carrying with pathogenic mutations, a total of 37 patients underwent pathological diagnosis, including 27 AML (1 TSC1 and 26 TSC2), 6 epithelioid AML (6 TSC2) and 4 RCC (1 TSC1 and 3 TSC2).